Skip to content

A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis

A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200610003
Enrollment
194
Registered
2020-06-10
Start date
2020-06-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter loss due to CRT or CRBSI Catheter lock Catheter related blood stream infection Catheter related thrombosis End stage renal disease Sodium bicarbonate Heparin

Interventions

7.5% sodium bicarbonate lock permanent catheter every hemodialysis sessions,heparin lock permanent catheter every hemodialysis sessions
Experimental Drug,Active Comparator Drug
7.5% sodium bicarbonate,heparin

Sponsors

Grant for research, Faculty of medicine, Chulalongkorn university
Lead Sponsor
The kidney foundation of Thailand
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients age more than 18 years old 2. Patients with maintenance chronic hemodialysis at least 2 sessions per week 3. Patients with permanent catheter as vascular access for hemodialysis

Exclusion criteria

Exclusion criteria: 1. Catheter dysfunction at baseline 2. On current anticoagulation therapy 3. Patients with known coagulopathy or hemophilia 4. Patients with cirrhosis Child-Pugh B or C 5. Patients with thrombocytopenia less than 100,000 u/L 6. Patients with central vessel stenosis and vena cava syndrome, previously documented. 7. Patients with heparin-induced thrombocytopenia 8. Patients with unstable condition within 1 month before enrollment 9. Patients with expected life expectancy less than 6 month

Design outcomes

Primary

MeasureTime frame
Catheter loss rate due to CRBSI and CRT 0, 3, 6 months record events per 6 months

Secondary

MeasureTime frame
Composite outcome of CRT, CRBSI, or ESI/TI rate 0, 3, 6 month percentage

Countries

Thailand

Contacts

Public ContactWannasit Wathanavasin

Division of nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University

kid_quey@hotmail.com0850181091

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026